tbuckley/cabot-search huggingface dataset:
Unraveling Long-Term Survival of Multiple Myeloma Patients, the GEM2000 Experience
Authors: Rafael Alonso Fernandez, Andrés Arroyo Barea, Maria Teresa Cedena Romero, Laura Rosiñol Dachs, Javier de la Rubia, Sara Miqueleiz, Veronica Gonzalez-Calle, Felipe De Arriba, Luis Felipe Casado Montero, Miguel Teodoro Hernandez, Maria Mas Esteve, Pascual Fernandez, Paula Rodríguez-Otero, Carmen Calle Primo, Eugenia Abella, Paz Ribas, Adrian Alegre, Juan Miguel Bergua, Irene Gomez-Catalan, Jose Maria Arguiñano Perez, Luis Palomera, Enrique M Ocio, Maria Jose Busto Medina, Nieves Somolinos, Jose Maria Alonso Alonso, Aránzazu García Mateo, Joan Bargay, Pilar Delgado, Dunia De Miguel Llorente, Javier de la Cruz, Maria Victoria Mateos, Jesús F. San-Miguel, Joan Bladé, Juan-Jose Lahuerta Palacios, Joaquin Martinez Lopez
Journal: Blood (2024)
<i>Ex Vivo</i> Treatment By Mitapivat, an Allosteric Pyruvate Kinase Activator, Reduced Hemolysis and Reactive Oxygen Species in Red Blood Cells of Non-Transfusion Dependent Hemolytic Anemic Patients Due to β-Thalassemia/Hb E Disease
Authors: Thidarat Suksangpleng, Kalaya Tachavanich, Vip Viprakasit
Journal: Blood (2024)
Improvement of Iron Overload Parameters in Patients with Transfusion-Dependent β-Thalassemia Treated with Luspatercept: Data from the Phase 3b Long-Term Rollover Study Following the BELIEVE Trial
Authors: John B. Porter, Maria Domenica Cappellini, Kevin H.M. Kuo, Maria Dimopoulou, Marta Reverte, Loyse Felber Medlin, Shweta Sharma, Kefeng Wang, Jennie Zhang, Ali T. Taher
Journal: Blood (2024)
Analysis of Chip Mutations Pre-and Post-Transplant in Multiple Myeloma (MM): Expanded Results from a Prospective Longitudinal Study
Authors: Sahar Khan, Salman Basrai, Esther Masih-Khan, Harjot Vohra, Donna Reece, Suzanne Trudel, Keith Stewart, Sita D. Bhella, Vishal Kukreti, Chloe Yang, Rodger E Tiedemann, Anca Prica, Aaron Schimmer, Sagi Abelson, Christine I Chen
Journal: Blood (2024)
Epidemiological Trends in Incidence, Death and Associated Risk Factors of Multiple Myeloma 1990-2021 and Projection to 2040
Authors: Rupayan Kundu, Niladri Kal, Abhay Singh, Louis Williams, Jack Khouri, Christy J. Samaras, Jason Valent, Shahzad Raza, Willem Van Heeckeren, Faiz Anwer, Sandra Mazzoni
Journal: Blood (2024)
Preclinical Proof-of-Concept of a Novel mRNA-Based Therapeutic Combination of an FcRH5 Targeted NK Cell Engager and an IL-15 Superagonist for the Treatment of Multiple Myeloma
Authors: Ailin Bai, Maija Garnaas, Zhen Zhang, Rebecca L Riding, Ankita Mishra, Kristen Cowens, Haley BrinJones, Khushbu Bhatt, John Zielinski, Matthew Sullivan, Anu Yammanuru, Graham MacLean, Sam Farlow, Russell Karp, John Eldredge, Maiko Obana, Darren Potz, Neeraj Kaushal, Christopher Rowbottom, Kenneth Drombosky, Linh Van, Graham Farrington, Brendan M. Weiss, Joshua P Frederick, Sushma Gurumurthy
Journal: Blood (2024)
Alterations in the Immune Phenotype of Adaptive Immune Cells in Sickle Cell Disease: A Conventional and Computational Flow Cytometry Analysis
Authors: Elisabeth Dovern, Tim R. Mocking, Mette D. Hazenberg, Cornelis R van der Torren, Boukje M. Beuger, Robin van Bruggen, Simon Tol, Erik Mul, Marjolein van der Pot, Arjan A. van de Loosdrecht, Myrddin Verheij, Karin Fijnvandraat, Carlijn Voermans, Bart J. Biemond, Costa Bachas, Erfan Nur
Journal: Blood (2024)
Fixed-Duration Epcoritamab in Combination with Bendamustine + Rituximab for First-Line Treatment of Follicular Lymphoma: Initial Results from Epcore NHL-2 Arm 3
Authors: Joshua Brody, Lorenzo Falchi, Umberto Vitolo, Marcel Nijland, Fritz Offner, Sylvia Snauwaert, Poliana Patah, Jennifer Marek, Christopher Morehouse, Andrew J. Steele, Yi Hao, Daniela Hoehn, Kim Linton
Journal: Blood (2024)
Understanding Barriers to Hematopoietic Cell Transplant (HCT) Access: Socio-Demographic Characteristics and Area Deprivation Index (ADI) of Patients Referred to the National Institutes of Health (NIH) for HCT
Authors: Cynthia Eleanya, Stacey Doran, Amy Chai, Rebecca Schwartz, Jessica Andrade, Dimana Dimitrova, Jennifer Hendricks, Mustafa A. Hyder, Rechache Kamil, Ruby Sabina, Jennifer Sponaugle, Christopher G. Kanakry, Jennifer A. Kanakry
Journal: Blood (2024)
Use of Steroids in Subjects with ITP in Spain: Duration and Toxicity
Authors: Maria Eva Mingot-Castellano, Beatriz Chiclana Rodriguez, Blanca Sánchez-González, Daniel Martinez Carballeira, Mariana Canaro Hinryk, Isabel Caparros Miranda, Denis Zafra, Aída Calo Pérez, Maria Cristina Pascual Izquierdo, Gonzalo Caballero Navarro, Marta Canet Maldonado, Maria Carmen Gómez del Castillo Solano, Amalia Cuesta Garcia, Patricia Alcalde Mellado, Marta García Culebra, Francesc Garcia-Pallarols, Lola Piquer Monsonis, Paula Sanchez Llorca, Diana Casares, Rocio Perez Montes, David Valcarcel, Begoña Pedrote Amador
Journal: Blood (2024)
Outcomes of Immunosuppressive Therapy in Children Less Than Three Years of Age with Idiopathic Severe Aplastic Anemia: A North American Collaboration
Authors: Talya Wittmann Dayagi, Laura Willis, Catherine Corriveau-Bourque, Michaela Cada, Zora R. Rogers, Taizo A. Nakano, Timothy S. Olson, Winfred C. Wang, Alfred Gillio, Thomas D. Coates, Anjulika Chawla, Paul Castillo, Peter Kurre, Christopher Gamper, Staci D. Arnold, Sarita Joshi, Amy E. Geddis, Jessica Boklan, Jennifer A. Rothman, James N. Huang, Gary M. Kupfer, Bertil Glader, Kelly J. Walkovich, Alexis Thompson, Rabi Hanna, David A. Williams, Akiko Shimamura, Yigal Dror
Journal: Blood (2024)
Dynamics of Complete Responses in Patients with Relapsed or Refractory Follicular Lymphoma Treated with Odronextamab in the ELM-2 Study
Authors: Stefano Luminari, Jose C. Villasboas Bisneto, Geoffrey Chong, David Tucker, Srikanth Ambati, Chinjune Lin, Hesham Mohamed, C. Akunna Otele, Giovanni Antico, Ana Jiménez Ubieto
Journal: Blood (2024)
Venetoclax Alone or in Combination Shows Promising Activity in Preclinical Models and Clinical Cases of Relapsed/Refractory North American Adult T-Cell Leukemia Lymphoma
Authors: Ankit Tanwar, Emma Cordover, Shikhar Sharma, Zixuan Tong, Kith Pradhan, Latoya S Townsend, Ioannis Mantzaris, Mendel Goldfinger, Nishi Shah, Aditi Shastri, Noah Kornblum, Dennis L Cooper, Ridhi Gupta, Simon Zhen, Nechama Dreyfus, Julie Nguyen, Lauren Shapiro, Eric J. Feldman, Ira Braunschweig, Beth McLellan, Alyssa de Castro, Xingxing Zang, Ali Bazarbachi, Murali Janakiram, Erik Guillen, Gregoire Lauvau, Eric Liu, Kira Gritsman, B. Hilda Ye, Amit Verma, Marina Konopleva, R. Alejandro Sica
Journal: Blood (2024)
Distinct Phenotypes of Myeloid Neoplasia Associated with Truncating <i>C-CBL</i> Mutations
Authors: Luca Guarnera, Carmelo Gurnari, Carlos Bravo-Perez, Arda Durmaz, Nakisha D Williams, Hussein Awada, Matteo D'Addona, Naomi Kawashima, Arooj Ahmed, Serhan Unlu, Olisaemeka Ogbue, Christopher Haddad, Aashray Mandala, Yasuo Kubota, Juraj Bodo, Genevieve M Crane, Heesun J. Rogers, Jaroslaw Maciejewski, Valeria Visconte
Journal: Blood (2024)
Quality of Life in the Multicenter, Randomized, Phase 3 GMMG-HD6 Trial Applying Elotuzumab, Lenalidomide, Bortezomib and Dexaemethason in Patients with Newly-Diagnosed Multiple Myeloma
Authors: Anna Fleischer, Elias K. Mai, Kaya Miah, Uta Bertsch, Britta Besemer, Mathias Hänel, Roland Fenk, Markus Munder, Christine Hanoun, Igor Wolfgang Blau, Christoph Mann, Christof Scheid, Roland Schroers, Ivana von Metzler, Aneta Schieferdecker, Jörg Thomalla, Peter Reimer, Rolf Mahlberg, Ullrich Graeven, Stephan Kremers, Uwe Martens, Christian Kunz, Manfred Hensel, Marc S. Raab, Katja C. Weisel, Hans Salwender, Imad Maatouk, Hartmut Goldschmidt
Journal: Blood (2024)
JNJ-87801493 (CD20xCD28), a Potential First-in-Class CD20 Targeted CD28 Costimulatory Bispecific Antibody, Enhances the Activity of B-Cell Targeting T-Cell Engagers in Preclinical Models
Authors: Lorena Fontan, Adam Zwolak, Irene Guimerans-Lorenzo, Mariette Bekkers, Nicholas Hein, Nele Vloemans, Emanuele Trella, Tina Smets, Ivo Cornelissen, Alemu Assefa, Bie Verbist, Ricardo Amorim, Pankaj Seth, Ranjeet Prasad Dash, Leopoldo Luistro, Bethany Mattson, Matthew A. Dragovich, Michael Hedvat, Gregory L. Moore, John R. Desjarlais, Olivia Kutlu, Joseph Erhardt, Ulrike Philippar
Journal: Blood (2024)
Acalabrutinib, Umbralisib and Ublituximab Regimen (AU2) Demonstrates High Response Rate and Undetectable Molecular Minimal Residual Disease (MRD) in Patients (pts) with <i>De Novo</i> Mantle Cell Lymphoma (MCL)
Authors: Paolo Lopedote, Geoffrey Shouse, Alexandra Muir, Carly Rolender, Peter Sportelli, Hari Miskin, Lu Chen, Tycel Phillips, Alexey Danilov
Journal: Blood (2024)
Unveiling the Burden of Diffuse Large B Cell Lymphoma in Paraguay: A Multicenter Study on Clinical Outcomes and Diagnostic Access
Authors: Seisha Alana von Glasenapp, Lorena Cardozo, Aline Nicole Paats, Alfredo Quiroz, Maria Elvira Enciso Arrua, Mercedes Royg Arriola, Rodrigo Santacruz, Jose Zarza, Perla Noemí Britos, Leticia Rocio Jiménez, Luis Enrique Malpica Castillo
Journal: Blood (2024)
Targeting Intracellular Mutant NPM1 in Acute Myeloid Leukemia with a Novel Peptide-MHC-Specific T-Cell Bispecific Antibody
Authors: Yunda Hong, Dabing Chen, Jingjing Xu, Yanxin Chen, Yangtao Wu, Yang Shi, Tianying Zhang, Quan Yuan, Ningshao Xia, Ting Yang, Jianda Hu
Journal: Blood (2024)
Preclinical Evaluation of Stx-0712, a CCR2 Cytotoxicity Targeting Chimera (CCR2-CyTAC) for the Treatment of Chronic Myelomonocytic Leukemia
Authors: Brandon Turunen, Craig Leach, Matthew Smith, Terra L. Lasho, Christy Finke, Abhishek A. Mangaonkar, Aref Al-Kali, Yael Kusne, Talha Badar, James M. Foran, Aisha Margaert, Michelle Baptista, Stephanie Wiltzius, Mrinal M. Patnaik
Journal: Blood (2024)
PLK1 Acts in Homologous Recombinatorial Repair and in Mitosis As Synthetically Lethal with the Fanconi Anemia/BRCA Pathway
Authors: Gary Kupfer, Paymon Doroodian, Jian Li, Erica Golemis, Paul Young, Emily Stahl, Arvin Nagarajan, Patrick Sung, Barbara Burtness
Journal: Blood (2024)
Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Combination with Daratumumab and Lenalidomide in Patients with Newly Diagnosed Multiple Myeloma: Safety and Efficacy Results from the Phase 1b Monumental-2 Study
Authors: Ajay K. Nooka, Tara Cochrane, Anita D'Souza, Jeffrey V Matous, Peter M. Voorhees, Karthik Ramasamy, Aurore Perrot, Andrew Spencer, Cyrille Hulin, Hang Quach, Deeksha Vishwamitra, Ashley Nguyen, Debopriya Ghosh, Elizabeth Shearin, Gary E Mason, Thomas Renaud, Gurdeep Parmar
Journal: Blood (2024)
Characterization of Erythrocytes in PNH: Can We Predict Response to Complement Inhibition Based on Different Erythrocyte Markers?
Authors: Elena E. Solomou, Alkmini Anastasiadi, Maria Papaioannou, Maria Angelopoulou, Panagiotis Zikos, Ioannis Assimakopoulos, Maria Dimou, Panagiotis Tsaftaridis, Jens Panse, Vasileios Tzounakas
Journal: Blood (2024)
Plinabulin and Selumetinib Enhance M1 Macrophage Traits and Trigger Cell Death in AML
Authors: Lucio Henrique Pinheiro, Isabel Weinhäuser, Diego A. Pereira-Martins, Luise Araujo De Albuquerque Simoes, Matthew Markham, Lynn Quek, Gerwin Huls, Jan Jacob Schuringa, Stuart A Rushworth, Eduardo M. Rego
Journal: Blood (2024)
Intrinsic and Microenvironmental Determinants of AML Response to HMA-Venetoclax Therapy at the Single-Cell Transcriptomic Level
Authors: Alfredo Marchetti, Francesca Lazzaroni, Matteo Claudio Da Vià, Alessio Marella, Antonio Matera, Akihiro Maeda, Nicolo Rampi, Claudia Leoni, Federico Mazzon, Elena Tagliaferri, Mariarita Sciumè, Marta Lionetti, Bruno Fattizzo, Francesco Passamonti, Nicola Stefano Fracchiolla, Niccolò Bolli
Journal: Blood (2024)
KP104, a Bifunctional C5 Mab-Factor H Fusion Protein, Demonstrates Sustained Long-Term Efficacy and Safety in Complement Inhibitor-Naïve PNH Patients: Updated Results from a Phase 2 Study at 36/38 Weeks of Obd Treatment
Authors: Fengkui Zhang, Li Zhang, Chen Yang, Changhe Yue, Jay Ma, Chaomei He, Ping Tsui, Qing Yu Christina Weng, Helen Fu, Hui Yan, Wenru Song, Bing Han
Journal: Blood (2024)
Clinical Activity of Tisagenlecleucel in Large B Cell Lymphomas According to the 5th Edition of the Who Classification
Authors: Guido Ghilardi, Emeline R. Chong, Luca Paruzzo, Giulia Gabrielli, Sunita D. Nasta, Vrutti Patel, Eugenio Fardella, Daniel J. Landsburg, Jordan Carter, Colin Thomas, Stefan K. Barta, Elise A. Chong, Jakub Svoboda, Marco Ruella, Stephen J. Schuster
Journal: Blood (2024)
Long-Term Follow-up of Crenolanib Maintenance after Allogeneic Transplantation in Newly Diagnosed and Relapsed FLT3 Mutated AML
Authors: Betul Oran, David Marin, Qaiser Bashir, Sairah Ahmed, Amanda L. Olson, Uday Popat, Partow Kebriaei, Elizabeth J. Shpall, Vinay Jain, Richard E. Champlin
Journal: Blood (2024)
Oncogenic Potential and Sensitivity to Menin Inhibitors of a Novel Fusion KAT6B::NUTM2B in Congenital Myeloid Sarcoma with Bone Marrow Involvement
Authors: Rebecca Voss, Wenqing Qi, Yen-Chun Liu, Jing Ma, La'Ron Browne, Mahsa Khanlari, Juan M Barajas, Melvin Thomas, Victor B Pastor Loyola, Hui Cao, Seth E. Karol, Jeffrey E. Rubnitz, Jeffery M Klco, Lu Wang
Journal: Blood (2024)
PCNSL Patients Treated with the Matrix Regimen in the Real World Have Similar Outcome to Those in the IELSG 32 Trial
Authors: Prokop Vodicka, Katerina Benesova, Andrea Janikova, David Belada, Veronika Hanackova, Heidi Mocikova, Juraj Duras, Katerina Steinerova, Eva Konirova, Tomas Prochazka, Kamila Polgarova, Jitka Dlouha, Petra Blahovcova, Marek Trneny
Journal: Blood (2024)
Automated Body Composition Analyses Reveal Significant Associations with Mortality in Myeloma Patients Following Immunotherapy with Bispecific Antibodies
Authors: Charles Agbuduwe, Dinh Van Chi Mai, Nikita Balaji, Amrutha Sridhar, Kathleen Cheok, Marzia Rahman, Conor Feely, Hanna Renshaw, Simon Wan, Charalampia Kyriakou, John T Jenkins, Rakesh Popat
Journal: Blood (2024)
Preclinical Activity of RAS(ON) Multi-Selective Inhibitor RMC-7977 and Therapeutic Combinations in AML with Signaling Mutations
Authors: Bogdan Popescu, Madison Piao, Sydney Abelson, Carolina E. Morales, Khadija Yousuf, Jose M. Rivera, Cheryl A C Peretz, Elliot Stieglitz, Catherine C. Smith
Journal: Blood (2024)
The Mitochondrial Unfolded Protein Response (UPRmt) Is Upregulated in Acute Myeloid Leukemia (AML) and Inhibiting the UPRmt Protease, LONP1, Leads to Mitochondrial Protein Aggregation and Cell Death Selectively in AML
Authors: Matthew Tcheng, Veronique Voisin, Marcela Gronda, Rose Hurren, Dakai Ling, Yongran Yan, Lan Xin Zhang, Yue Feng, Zaynab Mamai, Yulia Jitkova, Chaitra Sarathy, Andrea Arruda, Steven M. Kornblau, Mark D. Minden, Aaron D Schimmer
Journal: Blood (2024)
Risk Factors for Bleeding after Recent Medical Hospitalization: The Medical Inpatient Thrombosis and Hemostasis Study (MITH)
Authors: Mansour Gergi, Katherine Wilkinson, Andrew Sparks, Nicholas S Roetker, Hanny Al-Samkari, Nicholas L Smith, Timothy B Plante, Mary Cushman, Allen B Repp, Chris E. Holmes, Karlyn A. Martin, Neil Zakai
Journal: Blood (2024)
Combined Use of Ziftomenib and Selinexor Is Effective in NPM1 Mutant Acute Myeloid Leukemia
Authors: Sandhya Dhiman, Md. Hafiz Uddin, Vikram Dhillon, Jeff Justin Aguilar, Amro Aboukameel, Husain Khan, Sahar Bannoura, Jay Yang, Gregory Dyson, Steven Buck, Asfar Azmi, Lisa Polin, Francis Burrows, Linda Kessler, Jaroslaw Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood (2024)
Prognostic Analysis of Colorectal Extranodal Marginal Zone Lymphoma of MALT Type: Clinical Outcomes and Implications
Authors: Yeokyeong Shin, Jaewon Hyung, Hyungwoo Cho, Shin Kim, Chan-Sik Park, Heounjeong Go, In Hye Song, Jin-Sook Ryu, Sang-wook Lee, Dok Hyun Yoon
Journal: Blood (2024)
Understanding the Experiences of Caregivers for Children Five Years and Above Living with Sickle Cell Diseases in Kaduna, Nigeria
Authors: Halima Bello-Manga, Hayatu Musa, Bilkisu Usman, Kudirat Ahmed, Ifeoma Ijei-Enesi, Rhys Coleman, Abigail Picinich, Evelyn Lukanen, Nai Qashua, Allison A. King
Journal: Blood (2024)
Predicting Extravascular Hemolysis in Paroxysmal Nocturnal Hemoglobinuria
Authors: Munevver N. Duran, Zehra Tombul, Mutlu Mete, Ahmet Celal Toprak, Olisaemeka Ogbue, Hussein Awada, Carmelo Gurnari, Jaroslaw Maciejewski, Ibrahim F. Ibrahim, Merve Ozturk, Yusuf M. Ozcan, Brielle Johnson, Christine Ejiofor, Alper Olcal, Taha Bat
Journal: Blood (2024)
Long-Term Safety and Effectiveness of Ponatinib Treatment in Patients with TKI Intolerance: Subgroup Analysis of the Observational Study of Ponatinib Treatment in Patients with CML in Italy (OITI)
Authors: Massimo Breccia, Alessandra Iurlo, Fabrizio Pane, Anna Rita Scortechini, Immacolata Attolico, Marco Santoro, Marco Cerrano, Francesca Lunghi, Alessandro Maggi, Nicola Di Renzo, Valeria Sargentini, Alfonso Piciocchi, Claudia Tringali, Alessandra Malato
Journal: Blood (2024)
Clinical Validation of a Personalized NHL-TME Model System: One-on-One Comparison between Modeled Drug Responses and Patients' Clinical Responses
Authors: Shazia K. Nakhoda, Pin Lu, Tingwei Guo, Denise Connelly, Marcus Messmer, Zachary AK Frosch, Henry C. Fung, Asya Varshavsky Yanovsky, Y. Lynn Wang
Journal: Blood (2024)
Unraveling How Treatment Shapes Clonal Evolution and Resistance in Murine KMT2A-Rearranged Leukemia with Subclonal <i>KrasG12D</i>
Authors: Ton Falques, Mattias Pilheden, Larissa Helena Moura-Castro, Qirui Zhang, Louise Ahlgren, Helena Sturesson, Kajsa Paulsson, Axel Hyrenius Wittsten, Anna K. Hagstroem-Andersson
Journal: Blood (2024)
Transcriptomic Analysis of the Functions of CSF1R-Dependent Macrophages in Postnatal Development in the Rat
Authors: Dylan Carter-Cusack, Stephen Huang, Sahar Keshvari, Omkar Patkar, Anuj Sehgal, Rachel Allavena, Robert Byrne, Paul Morgan, Stephen Bush, Kim Z Summers, Katharine M Irvine, David A Hume
Journal: Blood (2024)
Direct Method for Estimating the Fraction of T and B/Plasma Cell-Derived DNA
Authors: Takeshi Sugio, Mohammad Shahrokh Esfahani, Soyeong Jun, Brian J. Sworder, Mark P. Hamilton, Hitomi Hosoya, Mari Olsen, Xiaoman Kang, Chih Long Liu, Feng Tian, David B. Miklos, David Kurtz, Maximilian Diehn, Ash A. Alizadeh
Journal: Blood (2024)
Outcomes of Relapsed/Refractory Multiple Myeloma Patients Receiving Sequential Therapies after Exposure to T-Cell Redirected or BCMA-Targeted Novel Immunotherapies
Authors: Rintu Sharma, Pamella Paul, Esther Masih-Khan, Eshetu G. Atenafu, Harjot Vohra, Sita D. Bhella, Christine I Chen, Vishal Kukreti, Guido Lancman, Donna E Reece, A. Keith Stewart, Rodger E Tiedemann, Chloe Yang, Suzanne Trudel
Journal: Blood (2024)
BVX001, a Bispecific ADC Targeting CD7-Positive AML with Favorable Toxicity Profile, Exhibits Significant Efficacy in Primary Patient Samples and PDX-Models
Authors: Mattia Vitale, Hollie B S Griffiths, Nyle Jones, Meera Mistry, Jack Sangster, Chloe Patterson, Samuel E O'Halloran, Adrian Blanco-Gomez, Oliver Schon, Tiffany Thorn (nee Daniels)
Journal: Blood (2024)
The Proteostasis Network Is a Therapeutic Target in Acute Myeloid Leukemia
Authors: Kentson Lam, Yoon Joon Kim, Carlo M. Ong, Andrea Z. Liu, Fanny Jiahua Jiahua Zhou, Bernadette A. Chua, Silvia Vicenzi, Pierce W. Ford, Jie-Hua Zhou, Eric Bennett, Leslie A Crews, Edward D. Ball, Robert Signer
Journal: Blood (2024)
“Endothelialized” Hemostasis-on-a-Chip Reveals Rapid Platelet Recruitment By Locally Concentrated Ultra-Large Von Willebrand Factor (VWF) Release from Endothelial Cells Surpasses Plasma and Platelet VWF in Initiating Hemostasis
Authors: Theodora T. Alese, Yumiko Sakurai, Elaissa L. Hardy, Wilbur Lam
Journal: Blood (2024)
Cellular and Cell-Free Genomic Characterization of Patients Receiving Avatrombopag and Immunosuppressive Therapy for Treatment-Naïve Severe Aplastic Anemia
Authors: Lucy C Fox, Sally Hunter, Stephen Ting, Le Thi Phuong Thao, Stephane Heritier, Anthony K. Mills, Dominic Pepperell, William S Stevenson, Ilona Cunningham, Jennifer Curnow, Devendra Hiwase, Robin Filshie, Kylie Mason, Sushrut S. Patil, Sonali Ashok Sadawarte, Frank Caleb Firkin, Jeffrey Szer, Paul Lacaze, Kate Wilson, Lisa Higgins, Lauren Young, Vanessa Fox, Robyn Sutherland, Neil A Waters, Erica M. Wood, Zoe K McQuilten, Piers Blombery
Journal: Blood (2024)
Bruton Tyrosine Kinase Inhibitor Rilzabrutinib Reduces Vaso-Occlusion and Markers of Inflammation and Adhesion in Transgenic Mice with Sickle Cell Disease
Authors: Ahmed Daak, David R. Light, Fuad Abdulla, Chunsheng Chen, Julia Nguyen, Conglin Ruan, Michael Storek, Dimitry Ofengeim, Alexandra Hicks, Michelle Lee, Vincent Mikol, Gregory M. Vercellotti, John D. Belcher
Journal: Blood (2024)
Predictive Value of Clonal Plasma Cells in Autografts Assessed By Next Generation Flow Cytometry on Pre-Transplant Bone Marrow MRD in Multiple Myeloma Patients
Authors: Ondrej Venglar, Eva Radova, David Zihala, Ivana Tvrda, Ludmila Muronova, Veronika Kapustova, Lucie Broskevicova, Jan Vrana, Tereza Popkova, Jana Mihalyova, Hana Plonkova, Tereza Sevcikova, Michal Kascak, Milan Navratil, Zdenek Koristek, Roman Hajek, Tomas Jelinek
Journal: Blood (2024)
A Multicenter Phase 2 Study Evaluating the Optimized Schedule of Belantamab Mafodotin 1.9 Mg/Kg Q8W Plus Bortezomib and Dexamethasone in Relapsed Refractory Multiple Myeloma
Authors: Tereza Popkova, Jakub Radocha, Martin Stork, Jiří Minařík, Jan Straub, Alexandra Jungova, Petr Pavlicek, Tomas Jelinek, Vladimir Maisnar, Ludek Pour, Tomas Pika, František Sedlák, Jan Soukup, Hana Plonkova, Ludmila Muronova, Viera Sandecka, Petra Krhovska, David Zihala, Roman Hajek
Journal: Blood (2024)
Bridging the Gap for Sickle Cell Disease Patient Data in Sub-Saharan Africa By Expanding Access to Specialty Biomarkers and Clinical Trials
Authors: Nnamdi Okeke, Divya Jain, Jennell U. White, Aliya U. Zaidi, Xiufeng Gao, Marta Ferranti, Rasa Borhan, Jordan Antongiorgi, Joseph Awalu, Chukwuka Udejiofor, Omolade Awed, Patrick C. Hines
Journal: Blood (2024)
The Efficacy and Safety of Obinutuzumab with Zanubrutinib As First-Line Treatment in Older Patients with Mantle Cell Lymphoma
Authors: Yanan Zhu, Yunfei Lv, Xingnong Ye, Juying Wei, Lixia Sheng, Ying Lin, Xiang Zhang, Xuewu Zhang, Hongyan Tong, Jie Jin, Wen-Juan Yu
Journal: Blood (2024)
Mass Spectrometry (MS)-Based Exent® Solution Reveals High Prevalence of Multiple M-Proteins in African American Patients with Multiple Myeloma (MM) and Precursor Conditions
Authors: David M Foureau, Oscar Berlanga, Cindy Varga, Barry Paul, Shebli Atrash, Christopher Ferreri, Semegne Hiruy, Lawrence J. Druhan, Ariel Bell, Phillip Holmes-Snowden, Gabriella Lakos, Peter M. Voorhees, Manisha Bhutani
Journal: Blood (2024)
A Senescent Subset in Human Hematopoietic Stem Cell (HSC) Compartment As Target for Senotherapy
Authors: Laura Poisa-Beiro, Jonathan JM Landry, Bowen Yan, Michael Kardorff, Volker Eckstein, Laura Villacorta, Anne-Claude Gavin, Judith Zaugg, Vladimir Benes, Simon Raffel, Daohong Zhou, Anthony D Ho
Journal: Blood (2024)
Frequent Loss of <i>HLA-B*40:02</i> from Leukocytes in Male Patients with Hepatitis-Associated Aplastic Anemia
Authors: Rio Takahashi, Yoshitaka Zaimoku, Kohei Hosokawa, Seishi Ogawa, Yoshiyuki Takahashi, Takako Miyamura, Yasushi Onishi, Takashi Koike, Tetsuya Nishida, Naoyuki Uchida, Noriko Doki, Masatsugu Tanaka, Tetsuya Eto, Mitsuhiro Itagaki, Masashi Sawa, Yuta Hasegawa, Takahiro Fukuda, Makoto Onizuka, Yoshiko Atsuta, Shinji Nakao, Takamasa Katagiri
Journal: Blood (2024)
Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial
Authors: Caroline Piatek, Jong Wook Lee, Morag Griffin, Jun-Ichi Nishimura, Christopher Patriquin, Hubert Schrezenmeier, Wilma Barcellini, Jamile Shammo, Anna Gaya, Mohammed Mahdi, Peng Liu, Karl-Johan Myren, Andrew Messali, Flore Sicre de Fontbrune, Jens Panse, Austin G. Kulasekararaj
Journal: Blood (2024)
Clonal Persistence of Anti-PF4 Antibodies in VITT Represents an MGTS-like State
Authors: Adam Kanack, Guillaume Roberge, Emily Mauch, Noah Splinter, Geoffrey D. Wool, Gemlyn George, Mouhamed Yazan Abou-Ismail, Kristi J. Smock, David L. Green, Krishna Gundabolu, Jon Coker, Mindy Kohlhagen, David Murray, Anand Pabmanabhan
Journal: Blood (2024)